search
Back to results

The "Step4Life" Randomized Control Trial in Hemodialysis

Primary Purpose

Physical Activity, End Stage Kidney Disease, Hemodialysis

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Fitbit
Sponsored by
University of California, San Diego
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Physical Activity

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

1) HD for ≥3 months, 2) age ≥18 years, and 3) ability to walk with or without assistive devices,

Exclusion Criteria:

1) wheelchair bound, 2) unstable severe health conditions (e.g., acute infections, heart failure (HF) NYHA class 4 and/or unstable angina), 3) hospitalization within 3 months before enrollment for non-access related reasons, or 4) clinically recognized cognitive impairment including dementia or psychosis.

Sites / Locations

  • University of California San Diego

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Fitbit plus Feedback Intervention

Fitbit alone

Arm Description

Participants who were randomized to the provider-feedback intervention arm received goal setting, and feedback graphs and charts,

Participants in self-managed control group were provided access to the Fitbit website or app but did not receive any feedback on their activity level from the study team.

Outcomes

Primary Outcome Measures

the absolute change from baseline in step counts per week from baseline to 12-weeks between randomized groups.
weekly step counts measured with Fitbit

Secondary Outcome Measures

Full Information

First Posted
February 4, 2022
Last Updated
February 4, 2022
Sponsor
University of California, San Diego
search

1. Study Identification

Unique Protocol Identification Number
NCT05241171
Brief Title
The "Step4Life" Randomized Control Trial in Hemodialysis
Official Title
The Impact of Use of a Wearable Pedometer and Structured Feedback Program on Physical Activity in Hemodialysis Patients: The "Step4Life" Randomized Control Trial
Study Type
Interventional

2. Study Status

Record Verification Date
February 2022
Overall Recruitment Status
Completed
Study Start Date
January 1, 2019 (Actual)
Primary Completion Date
April 30, 2020 (Actual)
Study Completion Date
May 30, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, San Diego

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
Persons with end-stage kidney disease (ESKD) have very low physical activity, and among ESKD patients, the level of inactivity is strongly associated with morbidity and mortality. This study aimed to assess the feasibility and effectiveness of a 12-week intervention coupling use of wearable pedometers (FitBit ®) and feedback coaching to increase physical activity in hemodialysis patients.
Detailed Description
Physical activity is an important modifiable behavior that is known to impact morbidity and mortality. The patients with advance kidney disease especially those on chronic hemodialysis are deconditioned with decreased muscle mass, and have co-morbidities such as anemia, malnutrition, and depression. These factors may explain why hemodialysis patients are known to have very low physical activity relative to healthy populations. We have recently demonstrated that hemodialysis patients are frequently sedentary, walk less with lower levels of physical activity. Thus, this provides an opportunity to design interventions to improve and sustain physical activity levels in hemodialysis patients. There is a growing experience of digital technology and intervention delivery modalities to promote physical activity in chronic comorbid conditions, but little is known in hemodialysis patients. We set forward to test a weekly coaching intervention guided by a wearable pedometer to determine whether it would be feasible, promote physical activity, and be sustained for 12 weeks in hemodialysis patients. Equipped with pedometer data, informing subjects quantitatively about their levels of physical activity relative to other hemodialysis patients, might promote physical activity in this high-risk population. We conduct a 12-week, open label, randomized controlled trial to determine the feasibility and effectiveness of providing structured feedback instruction (e.g., behavioral feedback, goal setting) along with a wearable pedometer (FitBit ®) in sustaining or improving physical activity levels in chronic hemodialysis patients as compared to the wearable pedometer (automated self-managed) alone. I hypothesized that the structured feedback intervention coupled with the wearable pedometer would be feasible, would improve physical activity, and would be sustainable for 12 weeks in hemodialysis patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Physical Activity, End Stage Kidney Disease, Hemodialysis

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
55 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Fitbit plus Feedback Intervention
Arm Type
Experimental
Arm Description
Participants who were randomized to the provider-feedback intervention arm received goal setting, and feedback graphs and charts,
Arm Title
Fitbit alone
Arm Type
Active Comparator
Arm Description
Participants in self-managed control group were provided access to the Fitbit website or app but did not receive any feedback on their activity level from the study team.
Intervention Type
Device
Intervention Name(s)
Fitbit
Intervention Description
The study participants in intervention group received feedback based on steps achieved every week (converted to average steps per day) after randomization.
Primary Outcome Measure Information:
Title
the absolute change from baseline in step counts per week from baseline to 12-weeks between randomized groups.
Description
weekly step counts measured with Fitbit
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 1) HD for ≥3 months, 2) age ≥18 years, and 3) ability to walk with or without assistive devices, Exclusion Criteria: 1) wheelchair bound, 2) unstable severe health conditions (e.g., acute infections, heart failure (HF) NYHA class 4 and/or unstable angina), 3) hospitalization within 3 months before enrollment for non-access related reasons, or 4) clinically recognized cognitive impairment including dementia or psychosis.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rakesh Malhotra, MD, MPH
Organizational Affiliation
University of California, San Diego
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California San Diego
City
San Diego
State/Province
California
ZIP/Postal Code
92101
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

The "Step4Life" Randomized Control Trial in Hemodialysis

We'll reach out to this number within 24 hrs